In addition, endostatin can reduce the expression levels of VEGF, TGF-β, IL-6, and IL-17 in tumor tissues, increase the expression levels of IFN-γ and HIF-1α, suppressing growth and angiogenesis of tumors (174). The gene discussed is VEGFA; the disease is neoplasm.